高级搜索

干细胞基因Lgr5在食管鳞癌组织中的表达及其临床意义

吕转, 李砺锋, 范智蕊, 马望, 王留兴

吕转, 李砺锋, 范智蕊, 马望, 王留兴. 干细胞基因Lgr5在食管鳞癌组织中的表达及其临床意义[J]. 肿瘤防治研究, 2016, 43(10): 863-869. DOI: 10.3971/j.issn.1000-8578.2016.10.008
引用本文: 吕转, 李砺锋, 范智蕊, 马望, 王留兴. 干细胞基因Lgr5在食管鳞癌组织中的表达及其临床意义[J]. 肿瘤防治研究, 2016, 43(10): 863-869. DOI: 10.3971/j.issn.1000-8578.2016.10.008
LV Zhuan, LI Lifeng, FAN Zhirui, MA Wang, WANG Liuxing. Expression and Clinical Significance of Stem Cells Gene Lgr5 in Esophageal Squamous Cell Carcinoma Tissues[J]. Cancer Research on Prevention and Treatment, 2016, 43(10): 863-869. DOI: 10.3971/j.issn.1000-8578.2016.10.008
Citation: LV Zhuan, LI Lifeng, FAN Zhirui, MA Wang, WANG Liuxing. Expression and Clinical Significance of Stem Cells Gene Lgr5 in Esophageal Squamous Cell Carcinoma Tissues[J]. Cancer Research on Prevention and Treatment, 2016, 43(10): 863-869. DOI: 10.3971/j.issn.1000-8578.2016.10.008

干细胞基因Lgr5在食管鳞癌组织中的表达及其临床意义

详细信息
    作者简介:

    吕转(1990-),女,硕士在读,主要从事肿瘤干细胞基础研究工作

    通讯作者:

    王留兴,E-mail:wlx2246@126.com

  • 中图分类号: R735.1

Expression and Clinical Significance of Stem Cells Gene Lgr5 in Esophageal Squamous Cell Carcinoma Tissues

More Information
  • 摘要:
    目的 

    探讨干细胞基因Lgr5在食管鳞癌组织及其成球细胞中的表达意义。

    方法 

    采用免疫组织化学法(IHC)检测280例食管鳞癌和150例癌旁组织中Lgr5蛋白的表达水平;低黏附培养法培养食管鳞癌细胞KYSE70形成成球细胞,Quantitative real-time PCR(qRT-PCR)、Western blot法检测干性相关基因SOX2、ALDH1A1、NANOG以及Lgr5在亲代细胞和成球细胞中的表达差异;Transwell实验检测成球细胞的迁移和侵袭能力、qRT-PCR法检测成球细胞中上皮间质转化(epithelial-mesenchymal transition, EMT)相关标志物Vimentin和N-cadherin的表达水平。

    结果 

    Lgr5在食管鳞癌组织的表达水平明显高于癌旁正常食管组织(P < 0.05),且与淋巴结转移、浸润深度、肿块大小、分化程度、肿瘤分期密切相关(均P < 0.05)。与亲代细胞相比,食管鳞癌成球细胞中干性相关基因SOX2、ALDH1A1、NANOG表达水平升高(均P < 0.05),Lgr5在食管鳞癌成球细胞中的表达水平也明显升高(P < 0.05),并且其迁移和侵袭能力增强(P < 0.05),EMT相关标志物Vimentin和N-cadherin的mRNA表达水平升高(均P < 0.05)。

    结论 

    Lgr5可能为食管鳞癌复发、进展、侵袭转移的标志之一,Lgr5高表达的食管鳞癌细胞可能具有干细胞样特性,并且可能为食管鳞癌细胞的一个干性调控基因。

     

    Abstract:
    Objective 

    To investigate the expression and clinical significance of stem cells gene Lgr5 in esophageal squamous cell carcinoma(ESCC) tissues and spheroid body-forming cells in ESCC.

    Methods 

    The expression level of Lgr5 was assessed in 280 cases of ESCC and 150 cases of normal esophageal squamous epithelia tissues by immunohistochemistry(IHC). Meanwhile, we developed spheroid body-forming cells in ESCC cell line KYSE70. The expression levels of stemness-related genes SOX2, ALDH1A1, NANOG and Lgr5 in spheroid body-forming cells and parental cells were detected via quantitative real-time PCR (qRT-PCR) and Western blot; the detection of Vimentin and N-cadherin, and Transwell experiment were performed to evaluate the invasion and migration abilities in spheroid body-forming cells.

    Results 

    The expression level of Lgr5 in ESCC was significantly higher, compared with normal esophageal squamous epithelia (P < 0.05). The high expression of Lgr5 was correlated with the tumor differentiation, lymph node metastasis, invasion, tumor size and AJCC stage (all P < 0.05). Compared with parental cells, the expression levels of SOX2, ALDH1A1 and NANOG were increased in spheroid body-forming cells (all P < 0.05); Lgr5 could up-regulate the expression levels of mRNA and proteins in spheroid body-forming cells (P < 0.05); the migration and invasion abilities of spheroid body-forming cells were increased (all P < 0.05); and the mRNA expression levels of Vimentin and N-cadherin were increased (all P < 0.05).

    Conclusion 

    Lgr5 may be a biomarker of recurrence, progression, invasion and migration of ESCC, and the overexpression of Lgr5 in ESCC may identify the ESCC' s stem-like properties, thus Lgr5 may be a gene of regulating stem-like properties in ESCC.

     

  • 图  1   免疫组织化学法检测食管鳞癌和癌旁正常组织中Lgr5蛋白的表达(SP ×400)

    Figure  1   Expression of Lgr5 in ESCC tissues and normal esophageal squamous epithelia tissues detected by immunohistochemistry (SP ×400)

    图  2   食管鳞癌细胞系KYSE70在无血清低黏附培养下形成的克隆细胞球

    Figure  2   ESCC KYSE70 cells formed spheroid bodies in serum-free medium at low adherence condition

    图  3   qRT-PCR法检测Lgr5在食管鳞癌KYSE70成球细胞和亲代细胞中mRNA表达水平

    Figure  3   mRNA expression levels of Lgr5 in ESCC KYSE70 spheroid body cells and parental cells evaluated by qRT-PCR

    图  4   Western blot法检测Lgr5在食管鳞癌KYSE70成球细胞和亲代细胞中蛋白表达水平

    Figure  4   Protein expression levels of Lgr5 in ESCC KYSE70 spheroid body cells and parental cells evaluated by Western blot

    图  5   qRT-PCR和Western blot法检测干性相关基因SOX2、ALDH1A1、NANOG在食管鳞癌KYSE70成球细胞和亲代细胞中的mRNA和蛋白表达水平

    Figure  5   mRNA and protein expression levels of stemness related genes SOX2, ALDH1A1, NANOG in ESCC KYSE70 spheroid body cells and parental cells evaluated by qRT-PCR and Western blot

    图  6   Transwell实验检测KYSE70成球细胞和亲代细胞的迁移侵袭能力

    Figure  6   Migration and invasion abilities of KYSE70 spheroid body cells and parental cells evaluated by Transwell

    图  7   qRT-PCR法检测Vimentin、N-cadherin在食管鳞癌KYSE70成球细胞和亲代细胞中mRNA表达水平

    Figure  7   mRNA expression levels of Vimentin and N-cadherin in KYSE70 spheroid body cells and parental cells evaluated by qRT-PCR

    表  1   Lgr5在人食管鳞癌和癌旁正常组织中的表达

    Table  1   Expression of Lgr5 in esophageal squamous cell carcinoma(ESCC) tissues and normal esophageal squamous epithelia tissues

    下载: 导出CSV

    表  2   Lgr5蛋白表达与食管鳞癌患者临床病理参数间的关系

    Table  2   Association between Lgr5 expression and clinicopathological features of ESCC patients

    下载: 导出CSV
  • [1] Ekman S, Dreilich M, Lennartsson J, et al. Esophageal cancer: current and emerging therapy modalities[J]. Expert Rev Anticancer Ther, 2008, 8(9): 1433-48.
    [1]

    Ekman S, Dreilich M, Lennartsson J, et al. Esophageal cancer: current and emerging therapy modalities[J]. Expert Rev Anticancer Ther, 2008, 8(9): 1433-48. doi: 10.1586/14737140.8.9.1433

    [2] Siegel R, Naishadham D, Jemal A, et al. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012, 62(1): 10-29.
    [2]

    Siegel R, Naishadham D, Jemal A, et al. Cancer statistics, 2012[J].CA Cancer J Clin, 2012, 62(1): 10-29. doi: 10.3322/caac.20138

    [3]

    Tachimori Y, Ozawa S, Numasaki H, et al. Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer[J]. J Thorac Cardiovasc Surg, 2014, 148(4): 1224-9. doi: 10.1016/j.jtcvs.2014.02.008

    [3] Tachimori Y, Ozawa S, Numasaki H, et al. Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer[J]. J Thorac Cardiovasc Surg, 2014, 148(4):1224-9.
    [4]

    Aminian A, Panahi N, Mirsharifi R, et al. Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery[J]. J Cancer Res Ther, 2011, 7(4): 448-53. doi: 10.4103/0973-1482.92016

    [4] Aminian A, Panahi N, Mirsharifi R, et al. Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery[J]. J Cancer Res Ther, 2011, 7(4): 448-53.
    [5] Dalerba P, Cho RW, Clarke MF, et al. Cancer stem cells: models and concepts[J]. Annu Rev Med, 2007, 58: 267-84.
    [5]

    Dalerba P, Cho RW, Clarke MF, et al. Cancer stem cells: models and concepts[J]. Annu Rev Med, 2007, 58: 267-84. doi: 10.1146/annurev.med.58.062105.204854

    [6] Liu J, Ma L, Xu J, et al. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties[J]. Int J Oncol, 2013, 42(2): 453-9.
    [6]

    Liu J, Ma L, Xu J, et al. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties[J]. Int J Oncol, 2013, 42(2): 453-9. doi: 10.3892/ijo.2012.1720/download

    [7]

    Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5[J]. Nature, 2007, 449(7165): 1003-7. doi: 10.1038/nature06196

    [7] Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5[J]. Nature, 2007, 44 9(7165): 1003-7.
    [8] Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459(7244): 262-5.
    [8]

    Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J].Nature, 2009, 459(7244): 262-5. doi: 10.1038/nature07935

    [9]

    Sato T, Clevers H. Primary mouse small intestinal epithelial cell cultures[J]. Methods Mol Biol, 2013, 945: 319-28. https://www.ncbi.nlm.nih.gov/pubmed/23097115

    [9] Sato T, Clevers H. Primary mouse small intestinal epithelial cell cultures[J]. Methods Mol Biol, 2013, 945: 319-28.
    [10] Horn LC, Schierle K, Schmidt D, et al. Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed mullerian tumors. Facts and background[J]. Pathologe, 2011, 32(3): 239-43.
    [10]

    Horn LC, Schierle K, Schmidt D, et al. Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed mullerian tumors. Facts and background[J].Pathologe, 2011, 32(3): 239-43. doi: 10.1007/s00292-010-1273-6

    [11]

    Jordan CT, Guaman ML, Noble M.Cancer stem cells[J]. N EngI J Med, 2006, 355(12): 1253-61. doi: 10.1056/NEJMra061808

    [11] Jordan CT, Guaman ML, Noble M.Cancer stem cells[J]. N EngI J Med, 2006, 355(12): 1253-61.
    [12] Simmini S, Bialecka M, Sato T, et al. Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2[J]. Nat Commun, 2014, 5: 5728.
    [12]

    Simmini S, Bialecka M, Sato T, et al. Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2[J]. Nat Commun, 2014, 5: 5728. doi: 10.1038/ncomms6728

    [13]

    Garza-Treviño EN, Said-Fernández SL, Martínez-Rodríguez HG. Understanding the colon cancer stem cells and perspectives on treatment[J]. Cancer Cell Int, 2015, 15(1): 2. doi: 10.1186/s12935-015-0163-7

    [13] Garza-Treviño EN, Said-Fernández SL, Martínez-Rodríguez HG. Understanding the colon cancer stem cells and perspectives on treatment[J]. Cancer Cell Int, 2015, 15(1): 2.
    [14]

    Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells[J]. Cancer Res, 2007, 67(3): 1030-7. doi: 10.1158/0008-5472.CAN-06-2030

    [14] Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells[J]. Cancer Res, 2007, 67(3): 1030-7.
    [15]

    Mathieu J, Zhang Z, Zhou W, et al. HIF induces human embryonic stem cell markers in cancer cells[J]. Cancer Res, 2011, 71(13): 4640-52. doi: 10.1158/0008-5472.CAN-10-3320

    [15] Mathieu J, Zhang Z, Zhou W, et al. HIF induces human embryonic stem cell markers in cancer cells[J]. Cancer Res, 2011, 71(13): 46 40-52.
    [16]

    Liu J, Wang L, Ma L, et al. Significantly increased expression of OCT4 and ABCG2 in spheroid body-forming cells of the human gastric cancer MKN-45 cell line[J]. Oncol Lett, 2013, 6(4): 891-6.

    [16] Liu J, Wang L, Ma L, et al. Significantly increased expression of OCT4 and ABCG2 in spheroid body?forming cells of the human gastric cancer MKN?45 cell line[J]. Oncol Lett, 2013, 6(4): 891-6.
    [17] Yue D, Zhang Z, Li J, et al. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer[J]. Exp Cell Res, 2015, 33 6(1): 141-9.
    [17]

    Yue D, Zhang Z, Li J, et al. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer[J]. Exp Cell Res, 2015, 336(1): 141-9. doi: 10.1016/j.yexcr.2015.06.007

    [18] 梁洪享, 钟竑, 罗勇, 等. 肿瘤干细胞标志物CD133、CD44、 SOX2、OCT4、ALDH1在非小细胞肺癌组织中的表达及临 床意义[J]. 肿瘤防治研究, 2013, 40(12): 1138-42. [Liang HX, Zhong H, Luo Y, et al. Expression and Significance of Cancer Stem Cell Markers CD133, CD44, SOX2, OCT4 and ALDH1 in Non-small Cell Lung Cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 20 13, 40(12): 1138-42.]
    [18] 梁洪享, 钟竑, 罗勇, 等.肿瘤干细胞标志物CD133、CD44、SOX2、OCT4、ALDH1在非小细胞肺癌组织中的表达及临床意义[J].肿瘤防治研究, 2013, 40(12): 1138-42. http://www.zlfzyj.com/CN/abstract/abstract4448.shtml

    Liang HX, Zhong H, Luo Y, et al. Expression and Significance of Cancer Stem Cell Markers CD133, CD44, SOX2, OCT4 and ALDH1 in Non-small Cell Lung Cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2013, 40(12): 1138-42. http://www.zlfzyj.com/CN/abstract/abstract4448.shtml

    [19]

    de Lau W, Barker N, Low TY, et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling[J]. Nature, 2011, 476(7360): 293-7. doi: 10.1038/nature10337

    [19] de Lau W, Barker N, Low TY, et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling[J]. Nature, 20 11, 476(7360): 293-7.
    [20]

    Carmon KS, Gong X, Lin Q, et al. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling[J]. Proc Natl Acad Sci U S A, 2011, 108(28): 11452-7. doi: 10.1073/pnas.1106083108

    [20] Carmon KS, Gong X, Lin Q, et al. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/betacatenin signaling[J]. Proc Natl Acad Sci U S A, 2011, 108(28): 11 452-7.
    [21] Plaks V, Brenot A, Lawson DA, et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis[J]. Cell Rep, 2013, 3(1): 70-8.
    [21]

    Plaks V, Brenot A, Lawson DA, et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis[J]. Cell Rep, 2013, 3(1): 70-8. doi: 10.1016/j.celrep.2012.12.017

    [22]

    da Silva-Diz V, Solé-Sánchez S, Valdés-Gutiérrez A, et al. Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis[J].Oncogene, 2013, 32(32): 3732-43. doi: 10.1038/onc.2012.375

    [22] da Silva-Diz V, Solé-Sánchez S, Valdés-Gutiérrez A, et al. Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis[J]. Oncogene, 2013, 32(32): 3732-43.
    [23] Nakata S, Campos B, Becker N, et al. LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells[J]. Brain Pathol, 2013, 23(1): 60-72.
    [23]

    Nakata S, Campos B, Becker N, et al. LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells[J]. Brain Pathol, 2013, 23(1): 60-72. doi: 10.1111/bpa.2013.23.issue-1

    [24] Becker L, Huang Q, Mashimo H, et al. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett’s esophagus and esophageal adenocarcinoma[J]. Dis Esophagus, 2010, 23(2): 16 8-74.
    [24]

    Becker L, Huang Q, Mashimo H, et al. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma[J]. Dis Esophagus, 2010, 23(2): 168-74. doi: 10.1111/des.2010.23.issue-2

图(7)  /  表(2)
计量
  • 文章访问数:  1374
  • HTML全文浏览量:  343
  • PDF下载量:  587
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-12-23
  • 修回日期:  2016-02-03
  • 网络出版日期:  2024-02-04
  • 刊出日期:  2016-10-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭